DNA Immunization for HIV Vaccine Development
DNA vaccination has been studied in the last 20 years for HIV vaccine research. Significant experience has been accumulated in vector design, antigen optimization, delivery approaches and the use of DNA immunization as part of a prime-boost HIV vaccination strategy. Key historical data and future ou...
Main Authors: | Yuxin Chen, Shixia Wang, Shan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/2/1/138 |
Similar Items
-
An Update on the HIV DNA Vaccine Strategy
by: Joseph Hokello, et al.
Published: (2021-06-01) -
HIV-1 Polymorphism: a Challenge for Vaccine Development - A Review
by: Morgado MG, et al.
Published: (2002-01-01) -
The Increase of the Magnitude of Spontaneous Viral Blips in Some Participants of Phase II Clinical Trial of Therapeutic Optimized HIV DNA Vaccine Candidate
by: Ekaterina Akulova, et al.
Published: (2019-08-01) -
Immunotherapy with an HIV-DNA Vaccine in Children and Adults
by: Paolo Palma, et al.
Published: (2014-07-01) -
Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines
by: Shixia Wang, et al.
Published: (2017-12-01)